Liqing Du Selected Research

ML216

12/2021

BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liqing Du Research Topics

Disease

20	Neoplasms (Cancer) 01/2022 - 03/2013
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 03/2013
6	Lung Neoplasms (Lung Cancer) 01/2022 - 06/2016
3	Inflammation (Inflammations) 04/2020 - 07/2013
2	Breast Neoplasms (Breast Cancer) 09/2021 - 10/2018
2	Enteritis 03/2021 - 10/2018
2	Genomic Instability 01/2021 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 12/2018 - 09/2018
2	Radiation Injuries (Radiation Sickness) 09/2014 - 07/2013
1	Atherosclerosis 09/2021
1	Weight Loss (Weight Reduction) 08/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2020
1	Hypersensitivity (Allergy) 01/2020
1	Carcinogenesis 01/2018
1	Nervous System Diseases (Neurological Disorders) 01/2018
1	Atrophy 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Multiple Myeloma 01/2018
1	Wounds and Injuries (Trauma) 01/2017
1	Colonic Neoplasms (Colon Cancer) 01/2014
1	Esophageal Neoplasms (Esophageal Cancer) 03/2013
1	Chromosome Aberrations (Chromosome Abnormalities) 10/2012

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 09/2021 - 07/2013
5	ResveratrolIBA 04/2020 - 07/2013
4	Sirtuin 1IBA 04/2020 - 07/2013
4	CaspasesIBA 12/2018 - 03/2013
3	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 12/2018
3	Biological ProductsIBA 10/2019 - 10/2012
2	Bloom syndrome proteinIBA 12/2021 - 01/2019
2	Peptides (Polypeptides)IBA 09/2021 - 05/2016
2	thymoquinoneIBA 03/2021 - 10/2018
2	InflammasomesIBA 04/2020 - 07/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2017
2	brusatolIBA 01/2020 - 06/2016
2	CytokinesIBA 01/2018 - 07/2013
2	NAD (NADH)IBA 01/2018 - 07/2013
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 12/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021
1	olaparibIBA 12/2021
1	ML216IBA 12/2021
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 12/2021
1	Radiation-Sensitizing AgentsIBA 09/2021
1	CarbonIBA 09/2021
1	Amino Acids FDA Link 09/2021
1	EnzymesIBA 08/2021
1	shellacIBA 08/2021
1	Inhibitor of Apoptosis ProteinsIBA 05/2021
1	trioctyl phosphine oxide (TOPO)IBA 01/2021
1	GadoliniumIBA 12/2020
1	AGuIXIBA 12/2020
1	InterleukinsIBA 04/2020
1	Biomarkers (Surrogate Marker)IBA 04/2020
1	MelatoninIBA 12/2018
1	Therapeutic UsesIBA 12/2018
1	Conditioned Culture MediaIBA 10/2018
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2018
1	Sirtuin 3IBA 09/2018
1	Actins (F Actin)IBA 01/2018
1	Circular RNAIBA 01/2018
1	carfilzomibIBA 01/2018
1	Proteasome InhibitorsIBA 01/2018
1	Fluorescein-5-isothiocyanate (FITC)IBA 05/2016
1	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA 09/2014
1	Small Interfering RNA (siRNA)IBA 01/2014
1	Pharmaceutical PreparationsIBA 07/2013
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 03/2013
1	RNA (Ribonucleic Acid)IBA 03/2013
1	Caspase 3 (Caspase-3)IBA 03/2013

Therapy/Procedure

17	Radiotherapy 01/2022 - 03/2013
7	Therapeutics 04/2020 - 03/2013
1	Chemoradiotherapy 01/2018